These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1411279

  • 1. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG, Chen D, Ihse I, Rehfeld JF, Håkanson R.
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [Abstract] [Full Text] [Related]

  • 2. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J, Håkanson R, Ihse I, Lilja I, Rehfeld JF, Sundler F.
    Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
    [Abstract] [Full Text] [Related]

  • 3. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG, Chen D, Rehfeld JF, Håkanson R.
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [Abstract] [Full Text] [Related]

  • 4. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.
    Gasslander T, Axelson J, Håkanson R, Ihse I, Lilja I, Rehfeld JF.
    Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
    Sundaram S, Dayan AD.
    Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
    [Abstract] [Full Text] [Related]

  • 9. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I, Lindenthal M, Schade M, Trautmann M, Adler G, Arnold R.
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
    Liehr RM, Reidelberger RD, Rosewicz S, Bussjaeger LJ, Solomon TE.
    Regul Pept; 1992 Apr 09; 38(3):207-19. PubMed ID: 1375383
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P, Olsen O, Gertz BJ, Gjorup I, Worning H.
    Scand J Gastroenterol; 1991 Jun 09; 26(6):627-37. PubMed ID: 1713709
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.
    Borgström A, Axelson J, Ihse I, Rehfeld JF.
    Pancreas; 1995 Aug 09; 11(2):179-84. PubMed ID: 7479676
    [Abstract] [Full Text] [Related]

  • 16. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A, Warzecha Z, Konturek SJ, Banas M, Cai RZ, Schally AV.
    J Physiol Pharmacol; 1991 Sep 09; 42(3):263-77. PubMed ID: 1665365
    [Abstract] [Full Text] [Related]

  • 17. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats.
    Wisner JR, Ozawa S, Xue BG, Renner IG.
    Pancreas; 1990 Jul 09; 5(4):434-8. PubMed ID: 1696382
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.